Synthetic Biology Market Professional Survey Report 2021

The global demand for synthetic biology market in terms of revenue was estimated to be USD 7.54 Billion in 2019 and is expected to reach USD 34.51 Billion in 2026, growing at a CAGR of 21.9% from 2020 to 2026.

The global synthetic biology market is expected to grow at a significant growth rate due to the number of driving factors.

Synthetic biology is a field of science which consists of redesigning of organisms for useful purposes with the help of engineering technique for making new abilities. It is the way of harnessing the power of nature to solve problems in medicine, manufacturing, and agriculture for researchers and companies around the world. Microorganisms harnessed for bioremediation to clean pollutants from water, soil, and air. It is used for designing and constructing new biological parts, devices, and systems as well as for re-designing of existing, natural biological systems for useful purposes. It has applications in various industries like diagnostics, cell reprogramming, therapeutics, enzymes, vaccines, biomaterials, biofuels, fine chemicals, and many more.

Get Sample Copy of The Report@ https://brandessenceresearch.com/requestSample/PostId/1446

The global synthetic biology market is expected to drive by the growing demand of synthetic biology in pharmaceutical and biotechnological companies for research and development purposes, government investment in science and technology for drug discovery and synthetic biological products and its applications in various industries. Synthetic biology is a multidisciplinary area of research that seeks to create new biological parts, devices, and systems, or to redesign systems that are already found in nature.

Prominent players of synthetic biology market:

The Top players in the synthetic biology market are Thermo Fisher Scientific Inc. (US), Twist Bioscience (US), Synthetic Genomics, Inc. (US), Codexis, Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Novozymes A/S (Denmark), Ginkgo Bioworks (US), Amyris, Inc. (US), Intrexon Corporation (US), GenScript Biotech Corporation (China), Cyrus Biotechnology Inc. (US), ATUM (US), TeselaGen (US), Arzeda (US), Integrated DNA Technologies, Inc. (US), Synthego Corporation (US), Creative Enzymes (US), Eurofins Scientific (Luxembourg) and New England Biolabs (US).

Segmentation Analysis of Synthetic Biology Market:

By Tools

  • Oligonucleotides

  • Enzymes

  • Synthetic Cells

By Technology

  • Gene Synthesis

  • Bioinformatics

By Application

  • Tissue Regeneration

  • Biofuel

  • Renewable Energy

  • Food & Agriculture

  • Bioremediation

Get Full Report :@ https://brandessenceresearch.com/biotechnology/synthetic-biology-market-size

Related Report:@ https://www.globenewswire.com/news-release/2021/02/02/2167936/0/en/At-21-9-CAGR-Synthetic-Biology-Market-Size-Expected-to-Reach-34-51-Bn-by-2026-Says-Brandessence-Market-Research.html